---
artifact:
  type: moderator-review
  from: MOD-W Moderator
  to:
    - Development Team
    - Tech Lead
  date: 2026-09-30
  review_artifacts:
    - prod-w/evidence-knowledge-model.md
    - mod-w/step-02.md
    - mod-w/reviews/TECH-LEAD-REVIEW-STEP-02.md
    - mod-w/domain-language.md
    - research/mod-w-transferability/observations.md
  review_status: APPROVED
---

# MOD-W Moderator Review: STEP-02

**Reviewer role:** MOD-W Moderator  
**Date:** 2026-09-30  
**Development Team work:** Approved  
**Tech Lead approval:** Approved  
**Status:** STEP-02 accepted

---

## Approval Record

The MOD-W Moderator approves the Development Team's work on STEP-02.

The MOD-W Moderator also approves the Tech Lead's approval of STEP-02, recorded in `mod-w/reviews/TECH-LEAD-REVIEW-STEP-02.md`.

### Moderator Confirmation

On 2026-09-30, the MOD-W Moderator reaffirmed:

- Development Team STEP-02 work is approved.
- Tech Lead's STEP-02 review / approval is approved.

---

## Accepted Artifacts

- `prod-w/evidence-knowledge-model.md`
- STEP-02 pending terms appended to `mod-w/domain-language.md`
- Proposed transferability observations appended to `research/mod-w-transferability/observations.md`

---

## Basis

The STEP-02 deliverable satisfies the acceptance checks in `mod-w/step-02.md`, as traced in `prod-w/evidence-knowledge-model.md` Section 14.3.

The Tech Lead review passed after revision and recorded no remaining blockers.

---

## Moderator Disposition

STEP-02 is accepted as of 2026-09-30.

---

## Addendum 2026-10-01: Open Question Carried to STEP-03

Recorded by QA at the MOD-W Moderator's direction, following `mod-w/reviews/PRODUCT-OWNER-SIGNOFF-STEP-02.md` condition B-1 (risk R-1). This records a question only. It does not answer it, ratify QA (3b) or the Product Owner sign-off (3c), or dispose of any other open defect.

### EK-OQ-17 - Authority to designate a change as a correction, and withdrawal of own counter-evidence

**Source:** `prod-w/evidence-knowledge-model.md` Section 6.7, EKR-10, EKJ-09, UAD-04, and Section 10.5 (withdrawal). `prod-w/evidence-knowledge-model.md` Section 13 is not edited by this addendum; this question is recorded here and must be added to STEP-03's inputs.

**Risk (R-1):** Acceptance carries over a correction (meaning unchanged, no trigger) but not a supersession. The model does not say who designates a post-acceptance change as a correction. If an item's own producer may do so, a meaning-changing edit to an independently accepted item could keep its acceptance and trigger nothing. That is the PR-16 self-approval failure arriving through item identity. EK-OQ-12 covers only how identity across change is represented, not this authority question.

**Questions STEP-03 must resolve:**
1. Who may designate a post-acceptance change as a correction rather than a supersession?
2. Must the original acceptor be notified or consulted?
3. May a producer's own correction designation on an accepted item retain acceptance without independent review?
4. May a producer withdraw its own item, including counter-evidence recorded against its own claim, without independent review? What visibility does that withdrawal require?

**Routing:** STEP-03. The Tech Lead may supply a recommendation when drafting `step-03.md`. A recommendation does not close the question; it is resolved only by an accepted STEP-03 artifact.

**Status:** Open. Pointer added to the STEP-03 row of `mod-w/roadmap.md` on 2026-10-01 at the Moderator's direction.

---

## Addendum 2026-10-01: Gate Ratification and Completion Re-record

Recorded by QA at the MOD-W Moderator's direction (Frank McGuire). The Moderator chose to ratify 3b and 3c and then re-record completion. QA drafted this wording. The Moderator confirmed the wording, and the three points below, on 2026-10-01 (commit `7cad830`): (1) the wording of this addendum; (2) QA D-02 to D-08 and Product Owner advisory items A-1 to A-9 remain open and undisposed; (3) no `step-02-complete` tag was created and the STEP-02 roadmap row is unchanged.

### What each acceptance is

The 2026-09-30 disposition above ("STEP-02 is accepted") did not say which acceptance it recorded. For clarity:

| MOD-W point | Acceptance | Record |
| --- | --- | --- |
| 1b | Step definition confirmed before briefing | `mod-w/step-02.md` change note, 2026-09-30 (`dcbcbe4`) |
| 2a | Plan approval | **Not held.** Briefing directed direct implementation (MW-OBS-012). Unchanged by this addendum. |
| 2b | Dev Team work product | Approved 2026-09-30 (this document, Approval Record) |
| 3a | Tech Lead review | Passed after revision, `mod-w/reviews/TECH-LEAD-REVIEW-STEP-02.md` |
| 3b | QA | Ratified below, `mod-w/reviews/qa.md` |
| 3c | Product Owner sign-off | Ratified below, `mod-w/reviews/PRODUCT-OWNER-SIGNOFF-STEP-02.md` |
| 4a | Completion (final gate) | Re-recorded below |

### Ratification

- **3b:** `mod-w/reviews/qa.md` is ratified as the Phase 3b record for STEP-02. Its Result (Fail) and defects D-01 to D-08 stand as written; ratification accepts it as the QA record, not as a pass.
- **3c:** `mod-w/reviews/PRODUCT-OWNER-SIGNOFF-STEP-02.md` (SIGNED_OFF_WITH_CONDITIONS) is ratified as the Phase 3c record. Its condition B-1 is met by EK-OQ-17 above. Its condition B-2 is met by this addendum. Its limits stand: the signer is a Claude-family subagent with limited independence, and it did not read `mod-w/domain-language.md`, `research/mod-w-transferability/observations.md`, `research/mod-w-transferability/adaptations.md` or `mod-w/roadmap.md`.
- **Visible exception, not routine conformance:** 3b and 3c ran after the 2026-09-30 acceptance, not before it. The ordering required by `mod-w/templates/MOD-W.md` was not followed. This is recorded as a sequence deviation, not as a waiver of either gate. D-01 is resolved by this ratification.

### Completion re-recorded

Completion of STEP-02 (Phase 4a) is re-recorded as of 2026-10-01, on the basis of 3a, 3b and 3c above.

**Not disposed by this addendum, and remaining open:**

- QA D-02: pending domain terms (`mod-w/domain-language.md`). The status text in that file ("Pending") is unchanged.
- QA D-03: MW-OBS-011 and MW-OBS-012 dispositions (status "Proposed" is unchanged), including their stale text.
- QA D-04: MW-ADAPT-001 re-evaluation at the STEP-02 gate.
- QA D-05: authority-adjacent choices not listed in Section 12 (confirmation by the Tech Lead or Moderator).
- QA D-06, D-07, D-08 and Product Owner advisory items A-1 to A-9.

The "Accepted Artifacts" list above is ambiguous about the pending terms and proposed observations. Until the Moderator disposes of D-02 and D-03, their own status text governs.

**Not done by this addendum:** no `step-02-complete` Git tag created (MOD-W 4a requires an annotated tag); `mod-w/roadmap.md` STEP-02 row unchanged.

---

## Addendum 2026-10-01: Remaining STEP-02 Defect and Advisory Dispositions

Recorded by Codex at the MOD-W Moderator's direction (Frank McGuire) after the Tech Lead follow-up review in `mod-w/reviews/TECH-LEAD-REVIEW-STEP-02-FOLLOWUP.md` (commit `8e200b1`). This addendum disposes the STEP-02 record items left open by the Gate Ratification and Completion Re-record addendum. It does not reopen `prod-w/evidence-knowledge-model.md` or write `step-03.md`.

### Basis

- `mod-w/reviews/qa.md` D-02 to D-08.
- `mod-w/reviews/PRODUCT-OWNER-SIGNOFF-STEP-02.md` advisories A-1 to A-9.
- `mod-w/reviews/TECH-LEAD-REVIEW-STEP-02-FOLLOWUP.md`.
- `mod-w/reviews/STEP-03-CARRY-FORWARD.md`.

### QA D-02 and D-06 - Domain terms

**Disposition:** Resolved by Moderator-authorized correction to `mod-w/domain-language.md`.

The MOD-W Moderator accepts the STEP-01 and STEP-02 proposed terms as accepted glossary terms while preserving their source-step provenance tables. The Moderator also accepts the Tech Lead recommendation to revise the accepted terms **Challenge** and **Inference** so they match the accepted STEP-02 model:

- **Challenge** may target an item, relationship, or decision, not only a claim, inference, or decision.
- **Inference** may be derived from cited evidence, assumptions, or other inferences; it must not be presented as evidence or observed fact.

The load-bearing STEP-02 terms Validation, Invalidation, Material dependency, Correction, Supersession, Withdrawal, Revalidation trigger, Revalidation requirement, and Exposure are accepted as the STEP-02 vocabulary baseline. STEP-03 may revise them through a later accepted change if gate, challenge, disagreement, or revalidation semantics require it.

### QA D-03 - Transferability observations

**Disposition:** Resolved by Moderator-authorized dispositions in `research/mod-w-transferability/observations.md`.

MW-OBS-011, MW-OBS-012, and MW-OBS-013 are accepted with Moderator dispositions appended. Their original bodies are not rewritten, even where later records supersede stale statements. The disposition text governs current status.

### QA D-04 - MW-ADAPT-001 re-evaluation

**Disposition:** Resolved by Moderator-authorized update to `research/mod-w-transferability/adaptations.md`.

The re-evaluation answer is:

1. **Did the declaration section produce findings?** Yes. STEP-02 Section 12 produced 16 declared choices, including architecture-adjacent UAD-04 to UAD-07.
2. **Did architecture-level or authority/revalidation-level content still slip past it?** Yes, partially. QA D-05 and the Tech Lead follow-up show that D-05a to D-05d met the declaration test but were not listed in Section 12. EK-OQ-17 also shows an architecture-adjacent self-approval risk around correction designation.

MW-ADAPT-001 remains active for STEP-03. It is strengthened by expectation: after the Development Team declaration, Tech Lead or QA should sample for unlisted choices in authority, independence, evidence standing, and revalidation before acceptance.

### QA D-05 - Undeclared authority and revalidation choices

**Disposition:** Resolved for STEP-02 by Tech Lead confirmation and Moderator ratification; carried to STEP-03 where specified.

The Moderator ratifies the Tech Lead follow-up dispositions:

| Ref | Moderator disposition |
| --- | --- |
| D-05a | Confirm as operationalization. AUTH-A may attach counter-evidence without gaining supporting-evidence, validation, challenge-closing, or gate authority. |
| D-05b | Confirm with STEP-03 change. Own-item withdrawal/supersession and authority over another actor's item must be separated in STEP-03, including the visibility rules for withdrawal of own counter-evidence. |
| D-05c | Confirm as operationalization. Human, independent closure is required where the dependent is a consequential decision or is cited by one. EK-OQ-16 remains for other non-decision dependents. |
| D-05d | Confirm as operationalization. EKR-18 is a valid affirmative evidence-conduct duty, with the model's stated detection limits. |

No accepted STEP-02 model text is changed by this disposition. STEP-03 must use these dispositions as inputs.

### QA D-07 - Stale delivery statement

**Disposition:** Resolved by this Moderator record; no edit to the accepted model.

The statement in `prod-w/evidence-knowledge-model.md` Section 15 that no accepted Roadmap or STEP-02 definition was modified is treated as a Development Team delivery statement about the STEP-02 product delivery, not as a complete account of later Moderator-owned status corrections. The later edits to `mod-w/roadmap.md` and `mod-w/step-02.md` were Moderator-authorized governance/status updates connected to STEP-02 acceptance. This addendum records that authorization explicitly so the discrepancy is not silent.

### QA D-08 - Challenge and bare contradicting claims

**Disposition:** Resolved for STEP-02 by routing and recommendation; must be decided in STEP-03.

The Moderator accepts the Tech Lead recommendation that STEP-03 widen EK-OQ-04 to cover both challenges and bare contradicting claims/inferences. STEP-03 must state whether each produces exposure, a revalidation requirement, or no dependent effect, and why bare contradicting claims/inferences are or are not treated differently from challenges and source-identified counter-evidence.

### Product Owner advisories A-1 to A-9

**Disposition:** Accepted as carry-forward guidance or resolved as record items below.

| Advisory | Disposition |
| --- | --- |
| A-1 | Accepted. EK-OQ-05 is first-priority STEP-03 entry work. |
| A-2 | Accepted. D-08/EK-OQ-04 must be widened as above. |
| A-3 | Accepted as STEP-03/STEP-04 consideration: identify assumption-rooted support where useful. |
| A-4 | Accepted as pilot/proof-of-concept observation target. |
| A-5 | Accepted as burden-check guidance for STEP-03/pilot work. |
| A-6 | Accepted as STEP-05 constraint: EKR-09, EKR-33, and EKR-40 do not select a ledger or central state model. |
| A-7 | Resolved by D-02/D-06 disposition above. |
| A-8 | Resolved by D-05 disposition above. |
| A-9 | Resolved by D-03, D-04, and D-07 dispositions above. |

### Completion effect

With this addendum, QA D-02 through D-08 and Product Owner advisories A-1 through A-9 are disposed for STEP-02. Open questions and advisory items routed to STEP-03 or later remain open in their target step; they no longer block STEP-02 completion.

The remaining STEP-02 completion action is the annotated Git tag `step-02-complete`.
